ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...

ReShape Lifesciences announced the granting of an international patent for its Diabetes Neuromodulation technology, which combines proprietary vagus nerve modulation with vagal stimulation aimed at ...

The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, ...

Pictured is the complete ExaStim® Stimulation System. · GlobeNewswire Inc. Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE)-- ANEUVO, a medical technology company advancing non-invasive ...

TAMPA, Fla. & NETANYA, Israel--(BUSINESS WIRE)--Neurolief, an innovator in neurotechnology, announces the company has received Food and Drug Administration (FDA) clearance for its Relivion® system.

Sonomind SAS raised €20 million (US$23 million) in a series A funding round for its ultrasound-based neuromodulation technology for depression. The funds will be used for clinical trials of the ...

A new study from Wake Forest University School of Medicine, published online in Global Advances in Integrative Medicine and Health, reveals that use of a brief, noninvasive intervention offers ...

The company's core technology is based on neuromodulation, using target electrical impulses to trigger specific physiological responses in the human body's central nervous system. Using electrical ...

Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, today announced it received 510(k) clearance from the U.S.